Bio-Rad Laboratories Inc (BIO-B) Stock Analysis

Bio-Rad Laboratories Inc (BIO-B) is a publicly traded company in the HEALTHCARE sector. It trades at $304.15, carries a market capitalization of $8.14B, a price-to-earnings ratio of 50.52. This page summarizes the public market data, fundamentals, and frequently asked questions for BIO-B, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

Market Sentiment

Bio-Rad Laboratories Inc currently has a Neutral sentiment score of 0.04.

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. (BIO-B) stands as a premier global innovator in the life sciences and clinical diagnostics sectors, renowned for its advanced product offerings that encompass reagents, instruments, and software tailored to enhance academic and clinical research. The company's diverse portfolio is critical in driving research across genomics, proteomics, and molecular biology, solidifying its reputation as a key partner for laboratories worldwide. With a steadfast commitment to scie...

GNG Research Analysis

GNG Research scores Bio-Rad Laboratories Inc (BIO-B) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BIO-B.

Frequently Asked Questions

Does BIO-B pay dividends?

Bio-Rad Laboratories Inc (BIO-B) does not currently pay a regular dividend.

What is BIO-B's P/E ratio?

Bio-Rad Laboratories Inc has a price-to-earnings (P/E) ratio of 50.52.

What is BIO-B's market cap?

Bio-Rad Laboratories Inc (BIO-B) has a market capitalization of $8.14B with a current stock price of $304.15.